Back to Search
Start Over
Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p6905-6905, 1p
- Publication Year :
- 2023
-
Abstract
- Background:Immunotherapy with Chimeric Antigen Receptor T cells (CAR-Τ) is worldwide commercially available for refractory B cell malignancies, with continuously expanding indications.Given that cytokine release syndrome (CRS) and neurotoxicity (ICANS) are encountered in many CAR-T recipients both in trials and real-world setting, novel predictive and prognostic markers are highly needed.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64591123
- Full Text :
- https://doi.org/10.1182/blood-2023-179506